Загрузка...
The First Frontier: Digital Biomarkers for Neurodegenerative Disorders
Current measures of neurodegenerative diseases are highly subjective and based on episodic visits. Consequently, drug development decisions rely on sparse, subjective data, which have led to the conduct of large-scale phase 3 trials of drugs that are likely not effective. Such failures are costly, d...
Сохранить в:
| Опубликовано в: : | Digit Biomark |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7015357/ https://ncbi.nlm.nih.gov/pubmed/32095743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477383 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|